By Waismann Method® | Opioid Dependence Experts
Reviewed by Clare Waismann, M-RAS, SUDCC II, Registered Addiction Specialist
Last reviewed: August 2026

Quick Answer

Waismann Method® was a hospital-based rapid detox program that operated in Southern California from 1998 to 2025. It combined a full in-hospital medical evaluation, anesthesia-assisted opioid antagonist detoxification performed by a board-certified anesthesiologist in an accredited private hospital, and several days of inpatient stabilization afterward at Domus Retreat, a private recovery center.

The program is closed. It no longer accepts patients and does not provide clinical services of any kind. It closed for two reasons. First, the founders concluded that rapid detox performed without at least a short period of inpatient medical stabilization is neither indicated nor safe, and delivering that full standard of care became financially impossible to sustain. Second, the greater unmet need turned out to be education: most people facing opioid dependence are never taught the underlying biology, and without that understanding they cannot evaluate their own options.

This site now exists as a free educational resource. If you need help finding treatment today, the SAMHSA National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357.

What Waismann Method Rapid Detox Was

Waismann Method® was founded in 1998 by Clare Waismann, M-RAS, SUDCC II, a Registered Addiction Specialist and Substance Use Disorder Certified Counselor. The name refers to a specific protocol for medically supervised opioid detoxification, not to a general category of treatment. There has only ever been one Waismann Method. The name is protected under U.S. federal trademark law, and the program was never licensed, franchised, or operated by any other organization. For a direct comparison against other providers using similar terminology, see how Waismann Method differed from other rapid detox centers.

The protocol was built around a single conviction: that opioid dependence is a medical condition affecting the central nervous system, not a moral failure, and that it therefore requires the same diagnostic rigor and physiological monitoring any other serious medical condition would receive. Over roughly 27 years, the program treated patients from across the United States and internationally at a single Southern California location.

Treatment operations ended in 2025. Everything described on this page is history. It is documented here because the record is useful to people who are still evaluating rapid detox as an option, and because the reasoning behind the closure is itself important information.

How the Waismann Method Rapid Detox Protocol Worked

The protocol had three phases, and the program’s position was that all three were mandatory. Rapid detox delivered as a standalone procedure was considered incomplete and unsafe. Common questions about the process are answered in more depth in the rapid detox FAQ.

Phase one: in-hospital medical evaluation

Patients were admitted to a private accredited hospital before any detoxification took place. The evaluation looked for cardiac, pulmonary, hepatic, renal, endocrine, and psychiatric conditions that could make anesthesia-assisted detox dangerous, along with the substances actually present in the patient’s system, which frequently differed from what the patient reported. Some patients were found to be unsuitable candidates during this phase and were not detoxed. Screening people out was treated as a function of the protocol, not a failure of it.

Phase two: anesthesia-assisted detoxification

Detoxification was performed in an intensive care setting by a board-certified anesthesiologist. Michael H. Lowenstein, MPH, M.D., a quadruple board-certified physician, served as medical director of the program. The procedure used intravenous sedation combined with opioid antagonists to displace opioids from receptor sites, compressing the acute physical withdrawal into a period the patient did not consciously experience. The antagonist medications involved, and how they continue to block opioid effects afterward, are covered separately in naltrexone therapy and Vivitrol.

This is the part of the protocol most people mean when they say “rapid detox,” and it is the part most often sold in isolation elsewhere. On its own, it was never the treatment.

Phase three: inpatient stabilization

Patients remained in the hospital after the procedure, then transferred to Domus Retreat, a private recovery center, for several days of continued care. This period addressed what the procedure itself does not resolve: disrupted sleep architecture, hypersensitivity, gastrointestinal dysfunction, blood pressure and heart rate instability, and the severe anxiety that commonly follows abrupt receptor clearance. Care included medical monitoring, nutritional support, and psychological support.

The clinical logic was straightforward. Clearing the receptors does not restore the nervous system. Restoration takes time, and the first days are when patients are least equipped to manage on their own.

Why Rapid Detox Without Inpatient Stabilization Is Not Safe

This is the most important section on this page, and it is the reason the program closed rather than continue in a reduced form.

Anesthesia-assisted rapid opioid detoxification places significant physiological stress on a body already destabilized by chronic opioid exposure. Documented mechanisms of injury include electrolyte disturbance, catecholamine surge, altered cardiopulmonary function, and acute lung injury. These events do not all occur on the table. Several present in the hours and days afterward, which is precisely the window during which an outpatient rapid detox patient has been sent home.

The public health record on this is unambiguous. In 2012, the New York City Department of Health and Mental Hygiene investigated an outpatient clinic performing rapid detox. Among 75 patients treated over a nine month period, two died and five more required hospitalization, a serious adverse event rate above nine percent. State and city health authorities subsequently issued a health alert advising providers against the procedure. An earlier practice recorded at least seven deaths across roughly 2,350 procedures.

The common thread in these cases is not the antagonist and not the anesthesia in isolation. It is the absence of a hospital, the absence of a full pre-procedure workup, and the absence of monitored recovery time afterward. A procedure that is defensible inside an accredited hospital with several days of inpatient stabilization becomes something else entirely when it is compressed into an outpatient visit for cost reasons. The differences between rapid detox centers are not cosmetic, and they are not marketing. They are the difference between a medical protocol and a procedure.

Fentanyl has made this worse rather than better. Its potency, its storage in fatty tissue, and its unpredictable elimination have changed what a safe detox protocol has to account for, as covered in rapid detox for fentanyl.

Delivering the full standard of care meant hospital admission, intensive care staffing, an anesthesiologist, a separate licensed recovery facility, and a clinical team on site around the clock. Those costs are real and they do not shrink. Continuing would have meant either operating at a loss indefinitely or cutting the elements that made the protocol safe. Cutting them was not an acceptable option, so the program closed.

Addiction is not a moral failure. It is a medical condition, and the people living with it deserve the same standard of care that any other serious condition receives. A program that cannot deliver that standard should not be delivering the procedure at all.

Clare Waismann, M-RAS, SUDCC II

Why This Site Now Publishes Education Instead

Nearly three decades of clinical work made one pattern impossible to ignore. Patients and families arrived with almost no understanding of what opioid dependence actually is at a biological level. They had been told it was a choice, a weakness, or a character defect. Almost no one had been told what happens to opioid receptors, to GABA and dopamine signaling, to the gut, to sleep, or to the endocrine system under sustained opioid exposure.

That gap has consequences. People who do not understand the mechanism cannot evaluate a treatment claim, cannot tell a rigorous protocol from a marketing pitch, cannot recognize when a facility is skipping steps that matter, and cannot advocate for themselves or a family member. They select treatment based on advertising, price, and desperation, and they are frequently harmed by that.

Filling that gap does not require a treatment program. It requires accurate, accessible information published without a sales motive behind it. That is what this site is now. There is nothing being sold here and no one to call. New material is published on the blog, and earlier discussions with clinicians and specialists are archived on the Waismann Method podcast.

The Biology Behind Opioid Dependence

Opioid receptors are distributed throughout the central nervous system and peripheral tissues, where they regulate both the body’s own opioids and those introduced from outside it. When an opioid binds to receptors on GABA-releasing neurons, GABA release is inhibited, which permits greater dopamine release. That is the mechanism behind euphoria. Binding at presynaptic terminals of nociceptive fibers blocks neurotransmitter release, which is the mechanism behind pain relief.

With sustained exposure, the system adapts. Receptor sensitivity changes, endogenous opioid production falls, and the nervous system recalibrates around the presence of the drug. That adaptation is physical dependence, and it is a measurable neurobiological change rather than a behavioral one.

When the drug is stopped or sharply reduced, the adapted system is left without the input it has restructured around. The result is withdrawal, which commonly includes nausea, vomiting, diarrhea, insomnia, anxiety, elevated body temperature, tachycardia, muscle and bone pain, sweating, chills, and elevated blood pressure. Severity and duration vary with the specific opioid, the dose, the duration of use, and the individual’s physiology. The gastrointestinal component is often the most underestimated, and is covered in detail in how opioids affect your digestive system.

Withdrawal symptoms are one of the primary drivers of continued use. This is why detoxification is a medical event and why the fear of it keeps people using long after they want to stop.

What to Ask If You Are Considering Rapid Detox Today

Rapid detox is still offered by various facilities. This site does not endorse or recommend any of them, and no referrals are made. If you are evaluating a provider, these are the questions that distinguish a serious medical protocol from a procedure being sold:

  • Where is the procedure performed? An accredited hospital with intensive care capability is a different setting from an outpatient surgical suite or an office.
  • What does the pre-procedure evaluation include? A full cardiac, pulmonary, hepatic, renal, and psychiatric workup, with toxicology, performed before the decision to proceed.
  • How many patients are turned away? A provider that has never declined a candidate is not screening.
  • How long is the monitored stay afterward, and where? Discharge on the same day or the next morning should be treated as disqualifying.
  • Who performs the procedure, and what are their board certifications?
  • What is the plan for the two weeks after discharge? Sleep, blood pressure, gastrointestinal function, and anxiety all need management during that window.

For a broader comparison of how protocols differ, see how rapid detox centers differ from one another and the rapid detox FAQ.

Detoxification by Substance

Withdrawal is not uniform. Half-life, potency, receptor binding profile, and tissue accumulation all change how withdrawal presents and how long it lasts, which is why the protocol was adjusted for each substance rather than applied identically. The opioid detox overview covers the general principles. Substance-specific detail is here:

Frequently Asked Questions

Is Waismann Method still open and accepting patients?

No. Waismann Method® ended treatment operations in 2025 after roughly 27 years. It does not accept patients, does not provide clinical services, and makes no referrals to other providers. This website is an educational resource only. For help locating treatment, contact the SAMHSA National Helpline at 1-800-662-4357.

Why did Waismann Method close?

Two reasons. The program’s clinical position was that rapid detox without at least a short period of inpatient medical stabilization is not indicated and not safe, and the cost of delivering that complete standard of care, including hospital admission, intensive care staffing, an anesthesiologist, and a separate inpatient recovery facility, became impossible to sustain. Rather than reduce the protocol to something cheaper and less safe, the program ended. The founders also concluded that the most urgent unmet need was education about the biology of opioid dependence, which is what this site now provides.

What was the difference between Waismann Method and other rapid detox programs?

The protocol required a full in-hospital medical evaluation before the procedure, performance of the procedure in an accredited private hospital rather than an outpatient setting, and several days of inpatient stabilization afterward at a dedicated recovery center. Many rapid detox offerings consist of the antagonist procedure alone, performed on an outpatient basis with same-day or next-day discharge.

How long did the Waismann Method program take?

Hospital admission and detoxification typically ran two to three days, followed by several additional days of inpatient care at Domus Retreat. The complete process generally spanned about a week, in contrast to outpatient rapid detox offerings that discharge patients within 24 to 48 hours.

Is rapid detox safe without an inpatient stay?

The evidence indicates it is not. A CDC-published investigation of an outpatient clinic in New York City found that among 75 patients, two died and five required hospitalization, a serious adverse event rate above nine percent, after which state and city health authorities advised providers against the procedure. Serious complications frequently present in the hours and days following the procedure, which is precisely when an outpatient patient has already been sent home.

What was Domus Retreat?

Domus Retreat was the private recovery center where Waismann Method patients stayed after hospital discharge. It provided continued medical monitoring, support for sleep regulation, gastrointestinal recovery and hypersensitivity, nutritional care, and psychological support during the days immediately following detoxification. It closed along with the treatment program in 2025.

Where can someone find opioid treatment now?

The SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and staffed 24 hours a day, 365 days a year, in English and Spanish. It provides referrals to local treatment facilities, support groups, and community organizations. SAMHSA also maintains a searchable treatment locator at findtreatment.gov. If someone is in immediate danger, call 911. For suicide or mental health crisis support, call or text 988.

Sources

Waismann Method® operated as an opioid treatment program from 1998 to 2025 and now publishes educational material drawn from that experience and from current public health and regulatory sources. This page is informational and is not a substitute for professional medical advice, diagnosis, or treatment. We are not a treatment provider, we do not offer clinical services, and we make no referrals. Always consult a qualified healthcare professional about your own situation. Waismann Method® is protected under U.S. federal trademark law.